NANCY BANH: Open Payments
NPI 1851925853 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 37 payments from 12 companies in 2025. Trend: 2023 $1,080 · 2024 $866 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $233 |
| BridgeBio Pharma, Inc. | 6 | $215 |
| Amgen Inc. | 3 | $80 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $23 |
Products named: Attruby, JARDIANCE, Repatha, VERQUVO, CAMZYOS, Kerendia, EVKEEZA, LifeVest.
Industry payments across HI — which companies pay providers there.
